Zepbound vs Wegovy: Which Is Better for Weight Loss in 2026?

Available online. Shipped directly to your door anywhere in the US.

Zepbound and Wegovy are the two most talked-about weight loss medications in the US right now. Google Trends data from 2026 shows that interest in Zepbound has now surpassed searches for Ozempic, the former category shorthand. Meanwhile, Wegovy remains the leading semaglutide brand for chronic weight management.

If you are trying to decide between Zepbound vs Wegovy, you are not alone. This guide compares the active ingredients, clinical trial results, side effects, cost, availability, and practical factors that should drive your choice. By the end, you will know which option is more likely to work for your body, your budget, and your long-term goals.

Zepbound vs Wegovy at a glance

How do Zepbound and Wegovy work?

Both medications belong to a class called incretin mimetics. They mimic gut hormones that your body releases after eating, triggering feelings of fullness, slowing stomach emptying, and reducing appetite. The key difference is that tirzepatide (Zepbound) targets two receptors — GLP-1 and GIP — while semaglutide (Wegovy) targets only GLP-1.

GIP, or glucose-dependent insulinotropic polypeptide, is another gut hormone involved in insulin release and fat metabolism. By combining GLP-1 and GIP activity, tirzepatide may produce stronger appetite suppression and greater fat loss than GLP-1 alone. This dual mechanism is the main reason researchers believe Zepbound shows higher average weight loss in head-to-head clinical data.

Clinical results: Zepbound vs Wegovy

The most important question is usually: which one helps you lose more weight? Here is what the clinical evidence shows:

Wegovy (semaglutide 2.4 mg) results

• STEP-1 trial: average weight loss of 14.9% over 68 weeks
• STEP-5 trial: sustained weight loss over 2 years
• About 86% of participants lost at least 5% of body weight
• FDA-approved for chronic weight management and cardiovascular risk reduction

Zepbound (tirzepatide) results

• SURMOUNT-1 trial: up to 22.5% average weight loss at 15 mg over 72 weeks
• SURMOUNT-5 trial: tirzepatide showed about 20.2% weight loss vs semaglutide's 13.7%
• About 91% of participants lost at least 5% of body weight at the highest dose
• FDA-approved for chronic weight management since Nov 2023

These are averages from clinical trials, not guarantees. Your actual results depend on your starting weight, dose, diet, activity level, genetics, and adherence. For a deeper dive into real-world timelines, read our GLP-1 before and after results guide.

Side effects: which medication is easier to tolerate?

Both Zepbound and Wegovy cause similar gastrointestinal side effects because they slow gastric emptying and affect appetite centers in the brain. The most common side effects include:

• Nausea
• Diarrhea
• Constipation
• Vomiting
• Abdominal pain
• Fatigue
• Headache

In general, tirzepatide has a slightly higher rate of GI side effects, especially at higher doses. However, both medications use a slow titration schedule that helps your body adjust. Starting at a low dose and increasing gradually every 4 weeks is the standard approach for both.

If you have a sensitive digestive system or a history of gastroparesis, gallbladder disease, or pancreatitis, discuss these risks with your provider. For a complete side effect guide, see our GLP-1 side effects article.

Cost comparison: Zepbound vs Wegovy

The list prices for brand-name Zepbound and Wegovy are nearly identical, typically $1,200 to $1,350 per month without insurance. But the out-of-pocket cost for you depends on several factors:

Because compounded semaglutide and tirzepatide cost 60 to 80% less, many US adults without brand-name insurance coverage turn to telehealth programs. For a full cost breakdown, read our GLP-1 cost without insurance guide.

Availability and shortages

Both brand-name Wegovy and Zepbound have experienced supply shortages due to surging demand. As of 2026, availability has improved, but some pharmacies still struggle to keep specific doses in stock. This is one reason compounded alternatives have become popular — they are often easier to obtain quickly.

If you want brand-name medication specifically, check with multiple pharmacies or consider a telehealth program that sources from licensed US compounding pharmacies. Compare GLP-1 telehealth options to see current availability.

Zepbound vs Wegovy: which should you choose?

There is no single "best" medication for everyone. Your choice should depend on your goals, health history, and budget. Here is a simple framework:

Choose Zepbound (tirzepatide) if:

• You want the strongest average weight loss results based on current trial data
• You tolerate GLP-1 medications well and want to try a dual-hormone approach
• Your insurance covers Zepbound or you can afford out-of-pocket cost
• You prefer compounded tirzepatide as a lower-cost alternative to Mounjaro/Zepbound

Choose Wegovy (semaglutide) if:

• You want a medication with a longer track record and more real-world data
• You are sensitive to GI side effects and want to start with a well-tolerated option
• Your insurance covers Wegovy or the manufacturer savings card applies to you
• You want the option of a daily oral semaglutide pill (Rybelsus off-label, or future Wegovy pill)

Compounded alternatives: the budget-friendly option

If neither brand-name medication is affordable or available, compounded tirzepatide or semaglutide through a licensed telehealth program is a legal and much cheaper option. These compounded versions contain the same active ingredient and are made by FDA-registered pharmacies during drug shortages.

For a full comparison of compounded vs brand-name semaglutide, read our compounded semaglutide guide. And for compounded tirzepatide specifically, see affordable compounded tirzepatide.

Frequently asked questions

Is Zepbound better than Wegovy for weight loss?

Clinical trials suggest tirzepatide (Zepbound) may produce greater average weight loss than semaglutide (Wegovy). SURMOUNT data showed up to 22.5% weight loss, while STEP trials with semaglutide showed about 14.9%. Individual results vary.

What is the difference between Zepbound and Wegovy?

Wegovy contains semaglutide, a GLP-1 receptor agonist. Zepbound contains tirzepatide, a dual GIP/GLP-1 receptor agonist. Tirzepatide targets two hormone pathways, which may explain stronger weight loss effects.

Is Zepbound more expensive than Wegovy?

Brand-name list prices are similar, around $1,200 to $1,350 per month. Actual cost depends on insurance, savings cards, and availability. Compounded alternatives cost $150 to $350 per month.

Can I get Zepbound or Wegovy online?

Yes. US telehealth programs can prescribe compounded semaglutide or tirzepatide after an online consultation and ship medication to your door. Brand-name prescriptions may be sent to a pharmacy.

Which has more side effects: Zepbound or Wegovy?

Both commonly cause nausea, diarrhea, and constipation. Tirzepatide has slightly higher GI side effect rates in trials. Both use gradual dose escalation to improve tolerance.

Conclusion

Zepbound and Wegovy are both powerful tools for chronic weight management. If you want the strongest trial data on average weight loss, Zepbound has an edge. If you prefer a medication with more long-term safety data and potentially easier tolerability, Wegovy remains an excellent choice.

Either way, the most important factor is getting a proper medical evaluation and finding an affordable, legal source. Check your BMI and compare US telehealth GLP-1 programs to get started today.

Affiliate disclosure: This article contains affiliate links. We may earn a commission if you sign up through them, at no extra cost to you. Medical disclaimer: This content is for informational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any medication.